Work

A phase II study of NALIRIFOX (liposomal irinotecan, 5-fluorouracil, leucovorin and oxaliplatin) in patients with locally advanced pancreatic cancer (LAPC).

Year: 2025

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e16447

Authors: Dong Xu, Nan Lv, Qianqian Wang, Yang Wu, Min Tu, Kuirong Jiang

Institutions: Jiangsu Province Hospital, Nanjing Medical University

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Servier

OpenAlex ID: W4410815587

FWCI:

Cites:

Cited by:

Related to: 10